FeesSafety
Pluang+

Viatris becomes Official Global Pharmaceutical Partner of Cadillac Formula 1 Team starting 2027.

Market News
16 Nov 2026, 16:00 WIB
PRNewsWire
View Source
Bullish
Viatris becomes Official Global Pharmaceutical Partner of Cadillac Formula 1 Team starting 2027.

Viatris Inc., a global healthcare company, has signed a multiyear deal to become the Official Global Pharmaceutical Partner of the Cadillac Formula 1 Team beginning with the 2027 season. This partnership connects two American companies focused on precision and innovation, as Cadillac aims to establish itself in Formula 1 and Viatris pursues new growth opportunities. The collaboration will help Viatris reach new global audiences while supporting the team's expansion and fan base growth in the U.S. and worldwide.

Viatris Inc. shares are trading near their 52-week high of $21.06, currently priced at $20.89 on Pluang as of Nov 16, 2026 21:12 WIB, showing a modest 1-day gain of 0.34%. This positions Viatris well above its 52-week low of $10.19, highlighting relative strength in the health sector. The stock's dividend yield stands at 2.3%, with a typical hold time of 57 days among Pluang investors.

More News (VTRS)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App